BP
TECH icon

Ballentine Partners’s Bio-Techne TECH Stock Holding History

Ballentine Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,469
Closed -$379K – 1061
2025
Q1 		$379K Buy
6,469
+2
+0% +$136 0.01% 539
2024
Q4 		$466K Buy
6,467
+53
+0.8% +$3.89K 0.01% 443
2024
Q3 		$513K Buy
6,414
+2
+0% +$150 0.01% 415
2024
Q2 		$459K Buy
6,412
+70
+1% +$5.15K 0.01% 423
2024
Q1 		$446K Buy
6,342
+66
+1% +$4.72K 0.01% 422
2023
Q4 		$484K Buy
+6,276
New +$413K 0.01% 370
2023
Q3 		– Sell
-2,740
Closed -$224K – 649
2023
Q2 		$224K Buy
+2,740
New +$220K 0.01% 522

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Ballentine Partners's TECH Position: Q2 2025 in Review

Ballentine Partners sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 6,469 shares — an estimated $379K sold.

Ballentine Partners first reported a position in TECH in Q2 2023 and held it in 7 quarters. The position peaked at $513K in Q3 2024. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • Ballentine Partners reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
  • Ballentine Partners sold 6,469 Bio-Techne shares in Q2 2025, an estimated $379K.
  • Ballentine Partners first reported a position in Bio-Techne in Q2 2023 and held it in 7 quarters.
  • Ballentine Partners's Bio-Techne position peaked at $513K in Q3 2024.
  • 556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Ballentine Partners's 13F filing for Q2 2025, filed 15 Jul 2025.